Need help choosing the right code?
Ask CasePilot about procedures, modifiers, bundling, and coding guidance.
Try CasePilot© Copyright 2026 American Medical Association. All rights reserved.
The procedure described by CPT® Code 69802 is known as labyrinthotomy with perfusion of vestibuloactive drug(s) and is performed in conjunction with a mastoidectomy. This surgical intervention is primarily indicated for the treatment of Meniere's disease, a condition characterized by episodes of vertigo, hearing loss, tinnitus, and a sensation of fullness in the ear. The labyrinth, which is the inner ear structure, consists of a complex system of canals and cavities that play a crucial role in balance and hearing. It is divided into two main components: the bony labyrinth, which provides structural support, and the membranous labyrinth, which contains the sensory organs. In this procedure, the surgeon accesses the inner ear through a transmastoid approach, which involves making an incision behind the ear to expose the mastoid bone. The mastoidectomy entails the removal of the air cell system within the mastoid bone, allowing for direct access to the inner ear structures. Once the labyrinth is accessed, it is opened and examined for any abnormalities. Subsequently, a needle or catheter is introduced into the inner ear, through which vestibuloactive drugs are instilled. These medications aim to alleviate the debilitating symptoms associated with Meniere's disease by targeting the vestibular system. The meticulous nature of this procedure requires the use of an operating microscope and specialized surgical instruments to ensure precision and minimize complications.
© Copyright 2026 Coding Ahead. All rights reserved.
The labyrinthotomy with perfusion of vestibuloactive drug(s) is indicated for the treatment of Meniere's disease, which is characterized by the following symptoms and conditions:
The procedure involves several critical steps to ensure effective treatment of Meniere's disease:
Post-procedure care involves monitoring the patient for any immediate complications and assessing the effectiveness of the drug instillation. Patients may experience some discomfort or temporary changes in hearing following the procedure. It is essential for healthcare providers to provide instructions regarding activity restrictions and signs of potential complications that should prompt immediate medical attention. Follow-up appointments are typically scheduled to evaluate the patient's recovery and the long-term effectiveness of the treatment.
| Short Descr | INCISE INNER EAR | Medium Descr | LABYRINTHOTOMY MASTOIDECTOMY | Long Descr | Labyrinthotomy, with perfusion of vestibuloactive drug(s); with mastoidectomy | Status Code | Active Code | Global Days | 090 - Major Surgery | PC/TC Indicator (26, TC) | 0 - Physician Service Code | Multiple Procedures (51) | 2 - Standard payment adjustment rules for multiple procedures apply. | Bilateral Surgery (50) | 1 - 150% payment adjustment for bilateral procedures applies. | Physician Supervisions | 09 - Concept does not apply. | Assistant Surgeon (80, 82) | 2 - Payment restriction for assistants at surgery does not apply to this procedure... | Co-Surgeons (62) | 0 - Co-surgeons not permitted for this procedure. | Team Surgery (66) | 0 - Team surgeons not permitted for this procedure. | Diagnostic Imaging Family | 99 - Concept Does Not Apply | APC Status Indicator | Discontinued Code | Type of Service (TOS) | 2 - Surgery | Berenson-Eggers TOS (BETOS) | none | MUE | Not applicable/unspecified. | CCS Clinical Classification | 24 - Mastoidectomy |
|
Date
|
Action
|
Notes
|
|---|---|---|
| 2012-01-01 | Deleted | Deleted |
| 2011-01-01 | Changed | Long description revised. Medium description changed. |
| Pre-1990 | Added | Code added. |
Get instant expert-level medical coding assistance.